Resources
About Us
Bone Growth Stimulators Market by Product (Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet Rich Plasma), Application (Spinal Fusion, Fracture, Oral Surgeries), End User (Hospital, ASC) - Global Forecast to 2030
Report ID: MRHC - 10478 Pages: 185 Jan-2023 Formats*: PDF Category: Healthcare Delivery: 24 to 48 Hours Download Free Sample ReportBone growth stimulators improve the body’s bone healing process in patients undergoing bone fusion surgeries. These stimulators can be worn outside or used during implantation therapies such as Cardiac Resynchronization Therapy (CRT) and Implantable Cardioverter-Defibrillator (ICD). It can heal bone fractures by applying electrical or ultrasound waves. This non-invasive bone healing treatment method is used as an alternative to bone grafts.
The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic diseases and injuries, and growing incidences of sports injuries. In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet-rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.
According to the United Nations Population Funds (UNFPA), the geriatric population has been growing at a faster rate in the past few years. Globally, the population aged 80 years or over is growing more rapidly than the younger population.
According to the data published by the United Nations (UN) Department of Economic and Social Affairs, the number of older people aged 65 years or over was 761 million in 2021. This number is expected to reach 1.6 billion by 2050. The number of people aged 80 years or over is growing rapidly. This growth is mainly attributed to increasing life expectancy, improvements in healthcare facilities, and declining fertility and mortality rates. According to data published by the Multidisciplinary Digital Publishing Institute (MDPI), hip fractures are expected to increase by 89% by 2025 globally compared to 2000, with nearly 800,000 fractures annually.
Furthermore, the population aged 50 and above is highly prone to orthopedic diseases, resulting in impaired posture and static & dynamic foot problems. By 2050, 130 million people will suffer from osteoarthritis worldwide, of which 40 million will be severely affected. (Source: The Modern Academic Journal Management System).
Thus, the growing geriatric population and the subsequent increase in the prevalence of orthopedic diseases are expected to drive the growth of the bone growth stimulators market during the forecast period.
Click here to: Get a Free Sample Copy of this report
Standard bone fracture management includes stabilization of the fracture site by internal or external fixation devices, compression devices or casting. Many factors can cause delayed union or non-union; however, diagnosis of the fracture depends on the pain and motion at the fracture site. Bone healing can be induced or enhanced through bone grafting or stimulators. The preference for stimulation treatments has been increasing in the last few years to overcome the drawbacks of bone graft surgeries. Bone graft surgeries may lead to an increase in the time for treatment and healing. It increases postoperative care and the need for multiple therapies.
Furthermore, the use of bone graft surgeries increases the cost of treatment. The average price for basic augmentation for a dental bone graft was around $200 to $1,200 for a single bone graft area in 2021. The cost of auto bone graft is much higher since it has two surgical sites. Moreover, patients also need to pay additional fees for other procedures, such as hospital admission, x-rays, and anesthesia. In addition, using bone grafts increases bone morbidity and disease transfer risk and may lead to immune-mediated rejection. It increases technical difficulties and postoperative bleeding, and there is a high chance of dehydration, impairing the stability of bone repair. Hence, surgeons prefer bone growth stimulators as they are convenient, easy to use, less complicated, non-operative, non-invasive, and have no risk of immunologic complications. Additionally, bone morphogenetic proteins (BMPs) serve as an alternative to autografts in some surgeries.
Thus, to reduce the risk associated with bone graft surgeries, the adoption of bone growth stimulators is increasing, subsequently driving the market’s growth.
Based on product, in 2023, the bone growth stimulation devices segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the increasing prevalence of non-union bone fractures and the growing preference for non-surgical treatment procedures. Bone growth stimulation devices are non-invasive and help promote healing after spinal fusion fractures or surgeries. These devices are often used to treat non-union bone fractures.
Based on the application, the bone growth stimulators market is segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral and maxillofacial surgeries, and other applications. In 2023, the spinal fusion surgeries segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the rise in spinal fusion surgeries, technological advancements in spinal surgery, and the high incidence rate of degenerative spinal disorders and conditions and obesity.
Based on end-user, in 2023, the hospitals & specialized clinics segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to increasing government and private organizations’ initiatives to increase and improve hospitals and specialized clinics and the continuous increase in the number of spinal fusion and orthopedic surgeries performed in hospital settings.
In 2023, North America is expected to account for the largest share of the bone growth stimulators market. North America’s major market share is mainly attributed to the availability of advanced technologies and the high adoption rate of innovative products in the healthcare sector in the region. Additionally, the increasing healthcare expenditures, the growing elderly population, and the rising incidence & prevalence of musculoskeletal diseases contribute to the growth of this regional market.
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market participants between 2020 and 2022. The key players profiled in the bone growth stimulators market report are Orthofix Medical Inc.(U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), DJO, LLC (U.S.), Bioventus LLC (U.S.), OssaTechnics BV (Germany), Arthrex GmbH (U.S.), Smith & Nephew plc (U.K.), and ITO CO., Ltd. (Japan).
Key questions answered in the report:
This study covers the market size and forecasts for various bone growth stimulation devices such as external bone growth stimulators, including Capacitive Coupling (CC) Devices, Combined Magnetic Field Devices (CMF), Pulsed Electromagnetic Field Devices (PEMF), Ultrasonic Bone Growth Stimulators, Implantable Bone Growth Stimulators, Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP).
The bone growth stimulators market is projected to reach $1.94 billion by 2030, at a CAGR of 4.9% from 2023 to 2030.
Based on product, in 2023, the bone growth stimulation devices segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the increasing prevalence of non-union bone fractures and the growing preference for non-surgical treatment procedures.
Based on application, in 2023, the spinal fusion surgeries segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the rising demand for spinal fusion surgeries, increasing technological advancements in spinal surgery, and growing incidences of degenerative spinal disorders and conditions and obesity.
Based on the end user, the ambulatory surgery center segment is projected to register the highest CAGR over the forecast period.
Based on geography, which region is expected to account for the largest share of the market in 2023?
Based on geography, in 2023, North America is expected to account for the largest share of the market. North America’s major market share is attributed to the remarkable advances in science and technologies, the high adoption rate of innovative products in the sector industry, high healthcare expenditure, the growing elderly population, and the high incidence & prevalence of musculoskeletal diseases in the region.
The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic diseases and injuries, and growing incidences of sports injuries. In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet-rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.
Key companies operating in the bone growth stimulators market are Orthofix Medical Inc.(U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), DJO, LLC (U.S.), Bioventus LLC (U.S.), OssaTechnics BV (Germany), Arthrex GmbH (U.S.), Smith & Nephew plc (U.K.), and ITO CO., Ltd. (Japan).
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholder
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Preference for Minimally Invasive Surgeries
4.2.2. Rising Cases of Bone Fractures and Spinal Injuries
4.2.3. Increasing Geriatric Population and Subsequent Increase in the Cases of Orthopedic Diseases & Injuries
4.2.4. Growing Incidences of Sports Injuries
4.3. Restraints
4.3.1. High Costs of Bone Morphogenetic Proteins (BMP) and Platelet-Rich Plasma (PRP) Products
4.4. Opportunities
4.4.1. Increasing Utilization of Platelet-Rich Plasma (PRP) in Multiple Therapy Areas
4.4.2. Growing Hospitals & Surgical Centers Worldwide
4.4.3. Emerging Economies
4.5. Challenges
4.5.1. Inadequate Medical Reimbursement Scenario for Bone Growth Stimulators
4.6. Impact of COVID-19 on Bone Growth Stimulators Market
4.7. Pricing Analysis
4.8. Regulatory Analysis
5. Bone Growth Stimulators Market, by Product
5.1. Introduction
5.2. Bone Growth Stimulation Devices
5.2.1. External Bone Growth Stimulators
5.2.1.1. Capacitive Coupling (CC) Devices
5.2.1.2. Combined Magnetic Field Devices (CMF)
5.2.1.3. Pulsed Electromagnetic Field Devices (PEMF)
5.2.2. Ultrasonic Bone Growth Stimulators
5.2.3. Implantable Bone Growth Stimulators
5.3. Bone Morphogenetic Proteins (BMP)
5.4. Platelet-Rich Plasma (PRP)
6. Bone Growth Stimulators Market, by Application
6.1. Introduction
6.2. Spinal Fusion Surgeries
6.3. Delayed Union & Non-union Bone Fractures
6.4. Oral and Maxillofacial Surgeries
6.5. Other Applications
7. Bone Growth Stimulators Market, by End User
7.1. Introduction
7.2. Hospitals & Specialized Clinics
7.3. Ambulatory Surgery Centers
7.4. Other End Users
8. Bone Growth Stimulators Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Market Share Analysis (2022)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Orthofix Medical Inc.
10.2. Zimmer Biomet Holdings, Inc.
10.3. Medtronic, plc
10.4. Stryker Corporation
10.5. Johnson & Johnson Private Limited
10.6. DJO, LLC
10.7. Bioventus LLC
10.8. OssaTechnics BV
10.9. Arthrex GmbH
10.10. Smith & Nephew plc
10.11. ITO CO., Ltd.
11. Appendix
11.1. Questionnaire
11.2. Available Customization
List of Tables
Table 1 Global Bone Growth Stimulators Market Drivers: Impact Analysis (2023–2030)
Table 2 Global Bone Growth Stimulators Market Restraints: Impact Analysis (2023–2030)
Table 3 Global Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 4 Global Bone Growth Stimulation Devices Market Size, by Country/Region, 2021–2030 (USD Million)
Table 5 Global External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 6 Global External Bone Growth Stimulators Market Size, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Capacitive Coupling (CC) Devices Market Size, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Combined Magnetic Field Devices (CMF) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Pulsed Electromagnetic Field Devices (PEMF) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Ultrasonic Bone Growth Stimulators Market Size, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Implantable Bone Growth Stimulators Market Size, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Bone Morphogenetic Proteins (BMP) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Platelet-Rich Plasma (PRP) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 15 Global Bone Growth Stimulators Market Size for Spinal Fusion Surgeries, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Bone Growth Stimulators Market Size for Union & Non-Union Bone Fractures, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Bone Growth Stimulators Market Size for Oral and Maxillofacial Surgeries, by Country/Region, 2021–2030 (USD Million)
Table 18 Bone Growth Stimulators Market Size for Other Applications by Country/Region, 2021–2030 (USD Million)
Table 19 Global Bone Growth Stimulators Market Size, by End Users, 2021–2030 (USD Million)
Table 20 Global Bone Growth Stimulators Market Size for Hospitals and Specialized Clinics, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Bone Growth Stimulators Market Size for Ambulatory Surgery Center, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Bone Growth Stimulators Market Size for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Bone Growth Stimulators Market Size, by Country/Region, 2021–2030 (USD Million)
Table 24 North America: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 25 North America: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 26 North America: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 27 North America: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 28 North America: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 29 North America: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 30 U.S.: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 31 U.S.: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 32 U.S.: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 33 U.S.: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 34 U.S.: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 35 Canada: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 36 Canada: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 37 Canada: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 38 Canada: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 39 Canada: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 40 Europe: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 41 Europe: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 42 Europe: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 43 Europe: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 44 Europe: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 45 Europe: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 46 U.K.: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 47 U.K.: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 48 U.K.: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 49 U.K.: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 50 U.K.: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 51 Germany: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 52 Germany: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 53 Germany: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 54 Germany: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 55 Germany: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 56 France: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 57 France: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 58 France: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 59 France: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 60 France: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 61 Spain: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 62 Spain: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 63 Spain: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 64 Spain: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 65 Spain: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 66 Italy: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 67 Italy: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 68 Italy: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 69 Italy: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 70 Italy: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 71 Rest of Europe: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 72 Rest of Europe: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 73 Rest of Europe: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 74 Rest of Europe: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 75 Rest of Europe: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 76 Asia-Pacific: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 77 Asia-Pacific: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 78 Asia-Pacific: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 79 Asia-Pacific: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 80 Asia-Pacific: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 81 Asia-Pacific: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 82 China: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 83 China: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 84 China: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 85 China: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 86 China: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 87 Japan: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 88 Japan: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 89 Japan: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 90 Japan: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 91 Japan: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 92 India: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 93 India: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 94 India: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 95 India: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 96 India: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 97 Rest of Asia-Pacific: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 98 Rest of Asia-Pacific: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 99 Rest of Asia-Pacific: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 100 Rest of Asia-Pacific: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 101 Rest of Asia-Pacific: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 102 Rest of Asia-Pacific: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 103 Latin America: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 104 Latin America: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 105 Latin America: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 106 Latin America: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 107 Latin America: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 108 Latin America: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 109 Brazil: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 110 Brazil: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 111 Brazil: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 112 Brazil: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 113 Brazil: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 114 Mexico: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 115 Mexico: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 116 Mexico: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 117 Mexico: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 118 Mexico: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 119 Rest of Latin America: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 120 Rest of Latin America: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 121 Rest of Latin America: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 122 Rest of Latin America: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 123 Rest of Latin America: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 124 Rest of Latin America: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 125 Middle East & Africa: Bone Growth Stimulators Market Size, by Country, 2021–2030 (USD Million)
Table 126 Middle East & Africa: Bone Growth Stimulators Market Size, by Product, 2021–2030 (USD Million)
Table 127 Middle East & Africa: Bone Growth Stimulation Devices Market Size, by Type, 2021–2030 (USD Million)
Table 128 Middle East & Africa: External Bone Growth Stimulators Market Size, by Type, 2021–2030 (USD Million)
Table 129 Middle East & Africa: Bone Growth Stimulators Market Size, by Application, 2021–2030 (USD Million)
Table 130 Middle East & Africa: Bone Growth Stimulators Market Size, by End User, 2021–2030 (USD Million)
Table 131 Recent Developments by Company (2020–2023)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Bone Growth Stimulators Market Size, by Product, 2023 VS. 2030 (USD Million)
Figure 8 Bone Growth Stimulators Market Size, by Application, 2023 VS. 2030 (USD Million)
Figure 9 Bone Growth Stimulators Market Size, by End User, 2023 VS. 2030 (USD Million)
Figure 10 Bone Growth Stimulators Market Size, by Geography
Figure 11 Market Dynamics
Figure 12 Bone Growth Stimulators Market Size, by Product, 2023 VS. 2030 (USD Million)
Figure 13 Bone Growth Stimulators Market Size, by Application, 2023 VS. 2030 (USD Million)
Figure 14 Bone Growth Stimulators Market Size, by End User, 2023 VS. 2030 (USD Million)
Figure 15 Bone Growth Stimulators Market Size, by Geography, 2023 VS. 2030 (USD Million)
Figure 16 North America: Bone Growth Stimulators Market Snapshot
Figure 17 Europe: Bone Growth Stimulators Market Snapshot
Figure 18 Asia-Pacific: Bone Growth Stimulators Market Snapshot
Figure 19 Latin America: Bone Growth Stimulators Market Snapshot
Figure 20 Bone Growth Stimulators Market: Competitive Benchmarking Based on Product
Figure 21 Global Bone Growth Stimulators Market: Market Share Analysis (2022)
Figure 22 Orthofix International N.V.: Financial Overview (2021)
Figure 23 Zimmer Biomet Holdings, Inc.: Financial Overview (2021)
Figure 24 Medtronic, plc: Financial Overview (2021)
Figure 25 Stryker Corporation: Financial Overview (2021)
Figure 26 Johnson & Johnson Services, Inc.: Financial Overview (2021)
Figure 27 Bioventus LLC: Financial Overview (2021)
Figure 28 Smith & Nephew plc: Financial Overview (2021)
Figure 29 ITO CO., Ltd.: Financial Overview (2021)
Published Date: Jun-2023
Published Date: Jan-2024
Published Date: Dec-2017
Published Date: Jul-2022
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates